What Sets Kailo Apart from the Competition


pain patch

Kailo is a pain patch that uses patented nanotechnology to boost the body's natural signals, meaning the brain can communicate more effectively with areas of the body experiencing pain. There are three products on the market that shape as possible competition, but when looked at closely, it is clear Kailo is leading the pack, and their competitor's technology does not stack up to what they offer.

Checks Every Box

Kailo was evaluated against three of its leading competitors, Signal Relief, Salonpas Pain Relief Patch, and Luminas, across eight categories and was the only product that checked every box. The eight categories were:

  • FDA registered
  • A clinical study with positive outcomes
  • Peer-reviewed published scientific article on clinical study results
  • Positive patient outcomes after 30 days of use
  • No drugs
  • One time purchase
  • Thousands of testimonials from actual patients
  • Available direct from the manufacturer

Positive Patient Outcomes

Most importantly, Kailo is the only pain patch on the market today that has seen positive patient outcomes after 30 days of use. None of the competitors, Signal Relief, Salonpas Pain Relief Patch, and Luminas, have achieved this result, with each falling short of what Kailo offers when it comes to results, which must be the defining factor in the success of a product.

In fact, of these companies, Kailo is the only one that has thousands of testimonials from actual patients verifying its effectiveness in relieving pain.

Cost-Effective

The Kailo pain patch is a one-off purchase. There are no additional costs associated with its use. Salonpas Pain Relief Patch and Luminas can not make this same claim with there being ongoing costs associated with their products.

This simple comparison between Kailo and the pain patch offered by three of its so-called leading competitors should leave consumers in no doubt that Kailo is the superior product, offering the best outcomes for patients and value for money.